- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
SkinBioTherapeutics
Market Cap: UK£42.1m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.16
7D
-5.9%
1Y
47.1%
Sprint Bioscience
Market Cap: SEK 59.1m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.56
7D
-0.4%
1Y
-56.5%
Valneva
Market Cap: €741.9m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€4.22
7D
-2.5%
1Y
53.9%
Fusion Antibodies
Market Cap: UK£20.5m
A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.
FAB
UK£0.18
7D
9.0%
1Y
319.5%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%
Galecto
Market Cap: US$5.6m
A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
GLTO
US$4.45
7D
55.1%
1Y
-61.7%
Relmada Therapeutics
Market Cap: US$54.8m
Operates as a clinical-stage biotechnology company in the United States.
RLMD
US$1.66
7D
0.6%
1Y
-49.4%
Veru
Market Cap: US$50.5m
A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).
VERU
US$3.59
7D
0.6%
1Y
-53.7%
Vincerx Pharma
Market Cap: US$209.4k
Operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States.
VINC
US$0.049
7D
22.6%
1Y
-99.6%
Revelation Biosciences
Market Cap: US$3.5m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$1.40
7D
-10.3%
1Y
-96.5%
COSCIENS Biopharma
Market Cap: CA$10.8m
A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.
CSCI
CA$3.45
7D
-2.8%
1Y
-35.3%
Gelteq
Market Cap: US$14.0m
Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.
GELS
US$1.35
7D
-7.5%
1Y
n/a
Caris Life Sciences
Market Cap: US$8.6b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$29.73
7D
-11.1%
1Y
n/a
Bio Green Med Solution
Market Cap: US$10.8m
Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.
BGMS
US$4.74
7D
5.1%
1Y
-98.0%
Entrada Therapeutics
Market Cap: US$183.1m
A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.
TRDA
US$5.58
7D
0.5%
1Y
-64.6%
NanoViricides
Market Cap: US$22.8m
A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
NNVC
US$1.40
7D
-1.4%
1Y
-1.4%
Matinas BioPharma Holdings
Market Cap: US$10.7m
A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.
MTNB
US$1.88
7D
8.7%
1Y
-47.3%
Syndax Pharmaceuticals
Market Cap: US$1.3b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$15.03
7D
-2.7%
1Y
-17.2%
Light AI
Market Cap: CA$22.9m
A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.
ALGO
CA$0.19
7D
-9.5%
1Y
n/a
TransCode Therapeutics
Market Cap: US$8.7m
A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.
RNAZ
US$9.92
7D
-11.7%
1Y
-98.3%
Arcutis Biotherapeutics
Market Cap: US$2.1b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$16.73
7D
-5.5%
1Y
82.6%
Nuvation Bio
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$3.01
7D
-5.0%
1Y
21.9%
Codexis
Market Cap: US$223.9m
Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
CDXS
US$2.40
7D
-3.6%
1Y
-22.6%
Ovid Therapeutics
Market Cap: US$99.6m
A biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.
OVID
US$1.41
7D
15.6%
1Y
25.9%
Attana
Market Cap: SEK 32.6m
Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.
ATANA
SEK 0.017
7D
0%
1Y
-79.0%
CBD Life Sciences
Market Cap: US$1.7m
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0004
7D
33.3%
1Y
-33.3%
Zhejiang Wecome Pharmaceutical
Market Cap: CN¥3.4b
Engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China.
300878
CN¥23.66
7D
-0.6%
1Y
54.4%
May & Baker Nigeria
Market Cap: ₦28.0b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦16.20
7D
-7.4%
1Y
123.4%
Hinova Pharmaceuticals
Market Cap: CN¥5.2b
A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.
688302
CN¥52.78
7D
-1.6%
1Y
72.0%
Citi Pharma
Market Cap: PK₨22.6b
Engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan.
CPHL
PK₨97.57
7D
0.7%
1Y
184.1%
Eisai
Market Cap: JP¥1.4t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥5,101.00
7D
-1.2%
1Y
-7.7%
Shandong Sito Bio-technology
Market Cap: CN¥2.8b
Researches, develops, and produces steroid biomedicine intermediates.
300583
CN¥14.86
7D
-3.9%
1Y
-9.7%
Merck
Market Cap: US$199.0b
Operates as a healthcare company worldwide.
MRK
US$77.60
7D
-4.8%
1Y
-31.4%
Biomm
Market Cap: R$1.2b
Operates as a biotechnology company in Brazil.
BIOM3
R$9.67
7D
12.2%
1Y
-3.3%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.5b
Produces and sells medicines in China.
600285
CN¥22.19
7D
-0.5%
1Y
-2.1%
Bora Pharmaceuticals
Market Cap: NT$84.4b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$680.00
7D
-1.4%
1Y
7.8%